Artificial Intelligence M&A Update, Q1 2025
Solganick has published its latest Artificial Intelligence (AI) M&A Update for Q1 2025.
Artificial Intelligence (AI) M&A Update 1H 2024
Solganick has published its latest industry report and update on the artificial intelligence industry. It covers mergers and acquisitions (M&A) in the sector for the first half of 2024.
The Next Phase of Artificial Intelligence (AI) Mergers and Acquisitions (M&A)
This article summarizes what’s next for artificial intelligence (AI) mergers and acquistions (M&A) including some of the companies that will lead buying in 2024+.
M&A is Active in Data Analytics
Solganick is reporting on the current M&A enviroment for data anaytics companies. Both Snowflake and Alteryx announced M&A transactions during the week of December 18, 2023.
Artificial Intelligence Industry Snapshot
Solganick has published its latest industry snapshot and M&A update on the artificial intelligence (AI) industry sector.
Solganick & Co. serves as exclusive advisor to Lone Star Analysis in its investment by HCAP Partners
October 31, 2019 – HCAP Partners, a San Diego-based mezzanine debt and private equity firm, announced today its investment in Lone Star Analysis, a Dallas-based provider of predictive and prescriptive data analytics and analysis. Terms of the transaction were not disclosed. Solganick & Co. was the exclusive advisor to Lone Star Analysis in this transaction. […]
Artificial Intelligence M&A and VC Funding Update, H1 2018
Los Angeles, CA – August 17, 2018 – Solganick & Co. issues its latest Artificial Intelligence (AI) M&A and VC Funding update for H1 2018. The following highlights the report, which can be downloaded here: Solganick Co Artificial Intelligence MnA Update H1 2018 Total US Artificial Intelligence M&A deals are on pace to hit 131 acquisitions […]
Solganick & Co. Served as Exclusive Advisor to Artificial Intelligence in Medicine In Its Sale to Inspirata
INSPIRATA ACQUIRES TORONTO-BASED ARTIFICIAL INTELLIGENCE IN MEDICINE, INC. (AIM) TO ENHANCE ITS R&D IN ARTIFICIAL INTELLIGENCE AND NATURAL LANGUAGE PROCESSING. Solganick & Co. Served As Exclusive Advisor to Artificial Intelligence in Medicine In Its Sale To Inspirata Tampa, FL and […]
